Globus Medical, Inc.
GMED
$71.04
$1.361.95%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 60.62% | 102.10% | 103.89% | 77.59% | 53.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 60.62% | 102.10% | 103.89% | 77.59% | 53.34% |
| Cost of Revenue | 65.47% | 131.21% | 161.99% | 122.44% | 87.92% |
| Gross Profit | 58.39% | 90.32% | 83.65% | 62.03% | 41.33% |
| SG&A Expenses | 52.42% | 88.09% | 90.03% | 69.62% | 48.90% |
| Depreciation & Amortization | 133.92% | 328.90% | 463.29% | 326.99% | 187.75% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 58.53% | 111.22% | 124.69% | 96.51% | 67.05% |
| Operating Income | 71.43% | 64.14% | 32.60% | 14.09% | 7.70% |
| Income Before Tax | -27.01% | -40.23% | -74.54% | -63.61% | -31.94% |
| Income Tax Expenses | -58.28% | -33.79% | -54.69% | -51.84% | -19.55% |
| Earnings from Continuing Operations | -16.19% | -42.05% | -80.09% | -66.89% | -35.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.19% | -42.05% | -80.09% | -66.89% | -35.39% |
| EBIT | 71.43% | 64.14% | 32.60% | 14.09% | 7.70% |
| EBITDA | 72.91% | 97.18% | 74.58% | 46.67% | 31.09% |
| EPS Basic | -35.88% | -57.22% | -85.30% | -68.13% | -37.55% |
| Normalized Basic EPS | 12.83% | 12.70% | -9.63% | -9.91% | 0.83% |
| EPS Diluted | -35.72% | -57.31% | -85.57% | -68.02% | -37.49% |
| Normalized Diluted EPS | 12.79% | 13.43% | -8.84% | -8.95% | 1.59% |
| Average Basic Shares Outstanding | 20.09% | 31.36% | 30.40% | 21.61% | 12.49% |
| Average Diluted Shares Outstanding | 20.05% | 30.37% | 29.19% | 20.23% | 11.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
